Publication #8500

Reference
PCA(P)(2025)17
Name
Extension to Serious Shortage Protocols for Estradot® (Estradiol) patches
Categories
Scottish Government PCA
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS Scotland Health Boards Special Health Boards Pharmacy Contractors Serious Shortage Protocols
Description
This circular advises Health Boards and community pharmacy contractors that two UK-wide Serious Shortage Protocols (SSPs) for Estradot® (estradiol) transdermal patches, a hormone replacement therapy (HRT) product, due to expire on 4 July 2025 have been extended until Friday 10 October 2025. 
The extension is applicable to SSP079 (50mcg strength Estradot® patch) and SSP082 (25mcg strength Estradot® patch), which allow community pharmacists to substitute a prescription of the noted Estradot® (estradiol) transdermal patches with the equivalent strength and same quantity of Evorel® (estradiol) transdermal patch or Estraderm MX® (estradiol) transdermal patch, for eligible patients, in accordance with these SSPs. 
Please note that the end date of all Estradot® (estradiol) transdermal patches SSPs is now the Friday 10 October 2025. This applies to SSP079 (50mcg strength Estradot® patch), SSP080 (75mcg strength Estradot® patch), SSP081 (100mcg strength Estradot® patch) and SSP082 (25mcg strength Estradot® patch). 
Community pharmacists are advised to review and familiarise themselves with the new end date for the above noted SSPs. 

Contact Name
Contact Email
pharmacyteam@gov.scot
Contact Address
Pharmacy & Medicines Division, 1st Floor East Rear, St Andrew’s House, Edinburgh, EH1 3DG
Contact Phone

Created
2025-07-03 09:34:00

Download URL
https://www.publications.scot.nhs.uk/files/pca2025-p-17.pdf

Click to go back to homepage